These scientists sought to answer a simple question. They ended up stumbling upon a discovery that could pave the way for a new generation of vaccines.
After the chaos of COVID-19,the world is bracing for the onset of the next “Disease X”.
Australia’s peak medicines industry group says it takes 466 days for approved medicines to become subsidised. Health Minister Mark Butler agrees that it’s too long.
Australians pay some of the lowest medicine prices in the world for a reason:our Pharmaceutical Benefits Scheme. Here’s how it works and why it’s being threatened.
Labor will bring the patient co-payment for subsidised medicines down to $25 from $31.60 as it wages an election battle over healthcare.
US medical giants say Australia’s Pharmaceutical Benefits Scheme is an “egregious and discriminatory” program that Trump should target in the next wave of tariffs.
The US president has already attacked Ireland’s pharmaceuticals industry. Australia fears our medicines could be next.
The mega-merger with pharmaceutical distributor Sigma Healthcare has minted billions for the pharmacy chain’s three founders and spawned more than 100 millionaires,with their stakes worth between $5 million and $25 million.
Hundreds of thousands of doses of moxidectin – which treats a disease caused by a parasitic worm – are being given to patients,the result of an audacious strategy offering a new way to develop medicine for neglected populations.
Australia imports about 90 per cent of its medicine,and this makes us incredibly vulnerable to any supply disruption. But it doesn’t have to be this way.